Misplaced Pages

The following pages link to Vorsetuzumab mafodotin

• (link count
• transclusion count
• sorted list) · See help page for transcluding these entries

Showing 50 items.

• Icrucumab (links | edit)
• Intetumumab (links | edit)
• Mogamulizumab (links | edit)
• Moxetumomab pasudotox (links | edit)
• Narnatumab (links | edit)
• Onartuzumab (links | edit)
• Teprotumumab (links | edit)
• Rilotumumab (links | edit)
• Girentuximab (links | edit)
• Radretumab (links | edit)
• Ublituximab (links | edit)
• Indatuximab ravtansine (links | edit)
• Daratumumab (links | edit)
• Racotumomab (links | edit)
• Yttrium (90Y) clivatuzumab tetraxetan (links | edit)
• Cantuzumab ravtansine (links | edit)
• Nivolumab (links | edit)
• Ocaratuzumab (links | edit)
• Demcizumab (links | edit)
• Patritumab (links | edit)
• Solitomab (links | edit)
• Nesvacumab (links | edit)
• Dusigitumab (links | edit)
• Imgatuzumab (links | edit)
• Vorsetuzumab (redirect page) (links | edit)
  • Tumor necrosis factor (links | edit)
  • TNF receptor superfamily (links | edit)
  • Lymphotoxin (links | edit)
  • Tumor necrosis factor superfamily (links | edit)
  • Lymphotoxin beta receptor (links | edit)
  • Tumor necrosis factor receptor 1 (links | edit)
  • Lymphotoxin alpha (links | edit)
  • Lymphotoxin beta (links | edit)
  • Tumor necrosis factor receptor 2 (links | edit)
  • Pegipanermin (links | edit)
  • Talk:Vorsetuzumab (links | edit)
  • User:Rich Farmbrough/wanted/drugs (links | edit)
  • Misplaced Pages:WikiProject Pharmacology/Lists of pages/Pharmacology articles (links | edit)
  • Misplaced Pages:WikiProject Pharmacology/Lists of pages/Pharmacology all pages (links | edit)
  • Misplaced Pages:WikiProject Chemistry/Lists of pages/Infobox drug articles (links | edit)
  • Misplaced Pages:WikiProject Pharmacology/Lists of pages/Infobox drug articles (links | edit)
  • Template:TNF receptor superfamily modulators (links | edit)
• Duligotuzumab (links | edit)
• Enoticumab (links | edit)
• Futuximab (links | edit)
• Parsatuzumab (links | edit)
• Simtuzumab (links | edit)
• Modotuximab (links | edit)
• Margetuximab (links | edit)
• Tovetumab (links | edit)
• Vantictumab (links | edit)
• Pembrolizumab (links | edit)
• Lilotomab (links | edit)
• Ontuxizumab (links | edit)
• Otlertuzumab (links | edit)
• CBR96-doxorubicin immunoconjugate (links | edit)
• Vadastuximab talirine (links | edit)
• Zolbetuximab (links | edit)
• Seagen (links | edit)
• Gatipotuzumab (links | edit)
• Monomethyl auristatin F (links | edit)
• Tarextumab (links | edit)
• Dinutuximab (links | edit)
• Emibetuzumab (links | edit)
• Lifastuzumab vedotin (links | edit)
• Sofituzumab vedotin (links | edit)
• Enfortumab vedotin (links | edit)